💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
Emerging “CCR5 ANTAGONISTS” Promising HIV Therapeutic Strategy
1. Presented By; Mahesh Shahi
3rd semester
Bachelor in Pharmaceutical
sciences,CCT
Emerging
“CCR5 ANTAGONISTS”
Promising HIV Therapeutic Strategy
t
Saturday, December 17,Saturday, December 17, 2016
2. Saturday, May 07, 2016
Pharmaceutical seminar~ 2nd
Contents
1. Quick review about HIV/AIDS
2. Treatment
3. Introduction
4. Chemistry
5. Mechanism of action of Maraviroc
6. Pharmacokinetics
7. Indications
8. Contraindications
9. Side effects
10. Drug Interactions
11. Doses
12. Precautions
13. Dosage forms
14. Storage
15. Conclusion
1
2
3. Saturday, December 17, 2016
Quick Review of the HIV/AIDs
2
INTRODUCTION HISTORY
TRANMISSION SYMPTOMS
TREATMENT
3
Pharmaceutical seminar~ 2nd
12. Saturday, December 17, 2016 11
DOSE
CATEGORY AGE GROUP DOSE
Younger below 18 year Not Available
Adult Above 18 year Available
Geriatric Above 65 year Not Available
12
Note: Use: In combination with other antiretroviral agents,
for patients infected with only CCR5-tropic HIV-1.
Pharmaceutical seminar~ 2nd
13. Saturday, December 17, 2016 12
DOSE IN DETAIL
With Potent CYP450 3A Inhibitors(e.g Nefazodone,
Clarithromycin)
150 mg orally twice a day
With Other Concomitant Medications (e.g Nevirapine,
Raltegravir, all NRTIs etc
300 mg orally twice a day
With potent CYP450 3A Inducers (e.g Carbamazepine,
Phenobarbital)
600 mg orally twice a day
13
Pharmaceutical seminar~ 2nd
14. Saturday, December 17, 2016 13
SIDE EFFECTS
1. Less Common
Difficulty having a bowel movement (stool)
Difficulty with moving
Increased or decreased appetite
2. More Common
Stomach discomfort or upset
Loss of interest or pleasure
Unusual tiredness
3. Rare
Convulsion
Vomiting of blood
Loss of voice
Difficulty with breathing
14
Pharmaceutical seminar~ 2nd